1 Apr 2025
🚫Analysis of Baijes Bissonnet Pharmacy DEA Registration Denial
Baijes Bissonnet Pharmacy; Decision and Order
Summary
The Drug Enforcement Administration issued a denial notice to Baijes Bissonnet Pharmacy, highlighting significant compliance failures related to controlled substances. The notice outlines allegations of neglecting red flags indicating prescription abuse and diversion, leading to substantial legal risks and regulatory consequences for the pharmacy.
Agencies
- Justice Department
- Drug Enforcement Administration
Business Impact
$$$ - High
The regulatory text discusses the denial of DEA registration for a pharmacy due to violations related to controlled substances. Business owners must understand the potential consequences of regulatory non-compliance, which can lead to substantial financial penalties and operational disruptions, especially in the pharmacy sector.